| Organism |
Homo sapiens, human |
| Cell Line Description |
In 1893, Dan L. Longo and Walter J. Urba established the RL cell line from the ascites of a 52-year-old Caucasian male diagnosed with non-Hodgkin lymphoma (NHL) affecting B cells. Since then, RL cells have been used as a model for studying B-cell NHL. The RL cell line can be used to create the CDX (cell line derived xenograft) RL xenograft mouse model. The RL xenograft model has been used as a model for studying non-Hodgkin lymphoma treatments (immunotherapy using antibody conjugates, etc.). |
| Tissue |
Ascites |
| Disease |
Lymphoma; Non-Hodgkin's |
https://www.creative-biogene.com/support/rl-cell-line.html
bio-equip.cn
Creative Biogene
Creative Biogene provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. Creative Biogene holds a leadership position in the global market and is committed to improving the human condition through biotechnology.
Creative Biogene is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.
Our Mission
To become the premier provider of innovative technologies, products, unique tools and services for research discoveries and product development in the areas of biological and biomedical research. Emphasis will be placed on the manufacture and distribution of genomics and proteomics based biological research reagent products of the highest possible quality, which include nucleic acid, protein and antibody based research reagent products and services.